We've got you covered
We are here to guide you in making tough decisions with your hard earned money. Drop us your details and we will reach you for a free one on one discussion with our experts.
or
Call us on: +917410000494
Alpa Laboratories Limited engages in manufacturing, marketing, and selling pharmaceutical finished dosage forms in India. It offers ethical, generic, and over the counter products in various finished dosage forms, including injections, tablets, capsules, eye and ear drops, ointments, creams, and gels for human use; and boluses, injections, and intra-mammary infusions for veterinary use. The company also provides drugs in various categories, such as anti-infectives comprising antibacterial, antibiotics, antifungals, antiprotozoals, and antivirals; analgesics; anti-inflammatory drugs; cough and cold drugs; cardiovascular drugs; anti-diabetics; nutritional supplements; psychotropic drugs; and skin care preparations, as well as ear and eye care preparations. It sells its products through distributors, retail chemists, retail pharmacy stores, and hospitals. The company also exports its products to South and Central America, Africa, and Asia, and CIS countries. Alpa Laboratories Limited was founded in 1967 and is based in Indore, India.
TODAY'S HIGH
68.95
TODAY'S LOW
65.9
52 WEEK HIGH
108.8
52 WEEK LOW
46.75
% of Shares Held by
All Insider
59.09%
% of Shares Held by
Institutions
0.00%
% of Float Held by
Institutions
0.00%
Number of Institutions
Holding Shares
0
MARKET CAP
144.11 Cr.
ETERPRISE VALUE
112.36 Cr.
NO. OF SHARES
2.10 Cr.
BOOK VALUE
57.011
DIV. YIELD
None%
DEBT
5.54 Cr.
GROSS PROFIT
32.79 Cr.
CASH
61.41 Cr.
REVENUE
112.09 Cr.
REVENUE/SHARE
53.255
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Investments | 7.90 Cr. | -11.60 Cr. | -11.87 Cr. | -17.97 Cr. |
| Change To Liabilities | 12.72 Cr. | -1.19 Cr. | 1.89 Cr. | -11.23 Cr. |
| Total cashflows from Investing Activities | 5.86 Cr. | -11.16 Cr. | -14.66 Cr. | -11.47 Cr. |
| Net Borrowings | 26.35 Lakhs | -1.27 Cr. | -4.32 Cr. | 9.89 Cr. |
| Total Cash from Financing Activities | 18.57 Lakhs | -1.34 Cr. | -4.77 Cr. | 8.83 Cr. |
| Other Liabilities | -53.94 Lakhs | 8.54 Lakhs | 3.27 Cr. | -16 Lakhs |
| Total Assets | 0 | 0 | 0 | 0 |
| Net Income | 7.24 Cr. | 1.85 Cr. | 1.01 Cr. | 2.80 Cr. |
| Change in Cash | 4.35 Cr. | 5.27 Cr. | -20.44 Cr. | -15.34 Cr. |
| Effect of Exchange Rate | 0 | 0 | 0 | 0 |
| Total Cash from Operating Activities | -1.69 Cr. | 17.78 Cr. | -1 Cr. | -12.70 Cr. |
| Depreciation | 1.22 Cr. | 1.14 Cr. | 1.09 Cr. | 1.04 Cr. |
| Other Cashflows from Investing Activities | 79.35 Lakhs | 1.61 Cr. | 3.85 Cr. | 4.28 Cr. |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Change to Inventory | -4 Cr. | 1.48 Cr. | -31.56 Lakhs | -68 Lakhs |
| Change to Account Receivables | -18.50 Cr. | 9.77 Cr. | -7.23 Cr. | -4.27 Cr. |
| Other Cashflows from Financing Activities | -7.78 Lakhs | -7.68 Lakhs | -44.92 Lakhs | -1.06 Cr. |
| Change to Net Income | 15.89 Lakhs | 4.63 Cr. | -72.51 Lakhs | -21.43 Lakhs |
| Capital Expenditures | -3.21 Cr. | -2.54 Cr. | -85.31 Lakhs | -1.97 Cr. |
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Research Development | None | None | None | None |
| Effect of Accounting Charges | None | None | None | None |
| Income Before Tax | 10.78 Cr. | 2.90 Cr. | 2.75 Cr. | 4.64 Cr. |
| Minority Interest | None | None | None | None |
| Net Income | 7.40 Cr. | 4.71 Cr. | 24.01 Lakhs | 3.31 Cr. |
| Selling General Administrative | 12 Cr. | 12.16 Cr. | 12.58 Cr. | 10.61 Cr. |
| Gross Profit | 32.79 Cr. | 30.69 Cr. | 24.88 Cr. | 23.03 Cr. |
| Ebit | 7.40 Cr. | 4.71 Cr. | 24.01 Lakhs | 3.31 Cr. |
| Operating Income | 7.40 Cr. | 4.71 Cr. | 24.01 Lakhs | 3.31 Cr. |
| Other Operating Expenses | 12.16 Cr. | 12.67 Cr. | 10.96 Cr. | 8.04 Cr. |
| Interest Expense | -2.61 Lakhs | -9.51 Lakhs | -47.68 Lakhs | -78.10 Lakhs |
| Extraordinary Items | None | None | None | None |
| Non Recurring | None | None | None | None |
| Other Items | None | None | None | None |
| Income Tax Expense | 3.53 Cr. | 1.05 Cr. | 1.74 Cr. | 1.83 Cr. |
| Total Revenue | 97.55 Cr. | 85.96 Cr. | 77.98 Cr. | 62.84 Cr. |
| Total Operating Expenses | 90.14 Cr. | 81.25 Cr. | 77.74 Cr. | 59.53 Cr. |
| Cost of Revenue | 64.75 Cr. | 55.27 Cr. | 53.09 Cr. | 39.81 Cr. |
| Total Other Income Expense Net | 3.38 Cr. | -1.80 Cr. | 2.51 Cr. | 1.32 Cr. |
| Discontinued Operations | None | None | None | None |
| Net Income from Continuous Ops. | 7.24 Cr. | 1.85 Cr. | 1.01 Cr. | 2.80 Cr. |
| Net Income Applicable to Common Shares | 7.24 Cr. | 1.85 Cr. | 1.01 Cr. | 2.80 Cr. |
| Particulars | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 |
|---|---|---|---|---|
| Intangible Assets | 5.51 Lakhs | 0 | 0 | 0 |
| Capital Surplus | 54.96 Cr. | 54.96 Cr. | 54.96 Cr. | 54.96 Cr. |
| Total Liabilities | 32.72 Cr. | 20.97 Cr. | 22.72 Cr. | 23.97 Cr. |
| Stock Holder Equity | 107.64 Cr. | 100.37 Cr. | 98.49 Cr. | 97.54 Cr. |
| Minority Interest | 0 | 0 | 0 | 0 |
| Other Liabilities | 6.21 Cr. | 5.66 Cr. | 6.25 Cr. | 3.71 Cr. |
| Total Assets | 140.36 Cr. | 121.35 Cr. | 121.21 Cr. | 121.52 Cr. |
| Common Stock | 21.04 Cr. | 21.04 Cr. | 21.04 Cr. | 21.04 Cr. |
| Retained Earnings | 31.64 Cr. | 24.37 Cr. | 22.49 Cr. | 21.54 Cr. |
| Other Liabilities | 21.60 Lakhs | -1 k | 1 k | 1 k |
| Good Will | 0 | 0 | 2.02 Cr. | 4.04 Cr. |
| Treasury Stock | 0 | 0 | 0 | 0 |
| Other Assets | 33.85 Lakhs | 1.37 Cr. | 60.13 Lakhs | 76.14 Lakhs |
| Cash | 1.80 Cr. | 4.97 Cr. | 14.91 Lakhs | 19.03 Lakhs |
| Current Liabilities | 32.50 Cr. | 20.78 Cr. | 22.31 Cr. | 23.36 Cr. |
| Long Term Asset Charges | 0 | 92.58 Lakhs | 17.10 Lakhs | 76.13 Lakhs |
| Short Long Term Debt | 18.29 Lakhs | 21.93 Lakhs | 20.24 Lakhs | 18.67 Lakhs |
| Other Stockholder Equity | 0 | 0 | 0 | 0 |
| Property Plant Equipment | 8.73 Cr. | 7.21 Cr. | 5.87 Cr. | 6.12 Cr. |
| Total Cur. Assets | 121.09 Cr. | 95.47 Cr. | 94.08 Cr. | 97.72 Cr. |
| Long Term Investments | 10.15 Cr. | 17.28 Cr. | 18.62 Cr. | 12.87 Cr. |
| Net Tangible Assets | 107.58 Cr. | 100.37 Cr. | 96.47 Cr. | 93.50 Cr. |
| Short Term Investments | 0 | 0 | 0 | 0 |
| Net Receivables | 38.12 Cr. | 26.57 Cr. | 37.73 Cr. | 35.76 Cr. |
| Long Term Debt | 91 k | 19.20 Lakhs | 41.13 Lakhs | 61.37 Lakhs |
| Inventory | 16.55 Cr. | 12.55 Cr. | 14.03 Cr. | 13.72 Cr. |
| Accounts Payable | 24.73 Cr. | 13.69 Cr. | 13.18 Cr. | 13.27 Cr. |
Open a demat account through us and get the account opening charges waived off
open paperless account